BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:52 PM
 | 
Aug 08, 2007
 |  BC Extra  |  Company News

Higher-dose Advair not approvable for COPD

GlaxoSmithKline (LSE:GSK; GSK) received a not approvable letter from FDA for an sNDA for Advair Diskus 500/50 (fluticasone/salmeterol) to treat chronic obstructive pulmonary...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >